Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

es Gatot Mudiantoro Suwondo Katherine M. Gehl Horst F. Geicke Jurgen M. Geissinger Paul Geitner Bekele Geleta Richard L. Gelfond Eli Gelman Pierre Gentin William W. George Julie Louise Gerberding David R. Gergen Valery Gergiev Valerie Germain Nataliya Germanova Tillman U. Gerngross Olaf Gersem

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ocieties (IFRC) Richard L. Gelfond Chief Executive Officer Imax Corporation USA Eli Gelman Chief Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Loui

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ocieties (IFRC) Richard L. Gelfond Chief Executive Officer Imax Corporation USA Eli Gelman Chief Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Loui

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

A Indonesia USA Hong Kong SAR Germany United Kingdom HOUSE_OVERSIGHT_017075 --- PAGE BREAK --- Bekele Geleta Richard L. Gelfond Eli Gelman Pierre Gentin William W. George Julie Louise Gerberding David R. Gergen Valery Gergiev Valerie Germain Nataliya Germanova Tillman U. Gerngross Olaf Gersemann M